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ABSTRACT
Arenaviruses are emerging viruses including several causative agents of severe hemorrhagic fevers in humans. The advent of
next-generation sequencing technology has greatly accelerated the discovery of novel arenavirus species. However, for many of
these viruses, only genetic information is available, and their zoonotic disease potential remains unknown. During the arenavi-
rus life cycle, processing of the viral envelope glycoprotein precursor (GPC) by the cellular subtilisin kexin isozyme 1 (SKI-1)/site
1 protease (S1P) is crucial for productive infection. The ability of newly emerging arenaviruses to hijack human SKI-1/S1P ap-
pears, therefore, to be a requirement for efficient zoonotic transmission and human disease potential. Here we implement a
newly developed cell-based molecular sensor for SKI-1/S1P to characterize the processing of arenavirus GPC-derived target se-
quences by human SKI-1/S1P in a quantitative manner. We show that only nine amino acids flanking the putative cleavage site
are necessary and sufficient to accurately recapitulate the efficiency and subcellular location of arenavirus GPC processing. In a
proof of concept, our sensor correctly predicts efficient processing of the GPC of the newly emergent pathogenic Lujo virus by
human SKI-1/S1P and defines the exact cleavage site. Lastly, we employed our sensor to show efficient GPC processing of a panel
of pathogenic and nonpathogenic NewWorld arenaviruses, suggesting that GPC cleavage represents no barrier for zoonotic
transmission of these pathogens. Our SKI-1/S1P sensor thus represents a rapid and robust test system for assessment of the pro-
cessing of putative cleavage sites derived from the GPCs of newly discovered arenavirus by the SKI-1/S1P of humans or any other
species, based solely on sequence information.
IMPORTANCE
Arenaviruses are important emerging human pathogens that can cause severe hemorrhagic fevers with highmortality in hu-
mans. A crucial step in productive arenavirus infection of human cells is the processing of the viral envelope glycoprotein by the
cellular subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P). In order to break the species barrier during zoonotic transmis-
sion and cause severe disease in humans, newly emerging arenaviruses must be able to hijack human SKI-1/S1P efficiently. Here
we implement a newly developed cell-based molecular sensor for human SKI-1/S1P to characterize the processing of arenavirus
glycoproteins in a quantitative manner. We further use our sensor to correctly predict efficient processing of the glycoprotein of
the newly emergent pathogenic Lujo virus by human SKI-1/S1P. Our sensor thus represents a rapid and robust test system with
which to assess whether the glycoprotein of any newly emerging arenavirus can be efficiently processed by human SKI-1/S1P,
based solely on sequence information.
Arenaviruses are a large and diverse family of emerging virusesthat includes several causative agents of severe hemorrhagic
fever in humans. The family Arenaviridae is currently classified
into Old World (OW) and New World (NW) virus groups (1).
OW arenaviruses include the prototypic lymphocytic choriomen-
ingitis virus (LCMV) and the highly pathogenic Lassa virus
(LASV). The NW viruses are divided into three clades (A, B, and
C), with clade B containing the South American hemorrhagic fe-
ver viruses Junin virus (JUNV), Machupo virus (MACV), Gua-
narito virus (GTOV), and Sabiá virus (SABV). New arenaviruses
continue to emerge at an increasing rate, and some of them have
been associated with human disease, as illustrated by Chapare
virus (CHAV), which emerged in Bolivia, and Lujo virus (LUJV),
isolated in a cluster of fatal hemorrhagic fever cases in southern
Africa (2, 3). The advent of powerful next-generation sequencing
technologies has greatly accelerated the discovery of novel arena-
virus species in mammals but also in other animals, including
snakes (4, 5) and, more recently, ticks (6). However, in many
cases, the viruses have not been isolated and the available sequence
information remains incomplete, preventing studies on viral rep-
lication in human tissue culture.
Arenaviruses are enveloped negative-strand RNA viruses with
a nonlytic life cycle (7). Their genome consists of two single-
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stranded RNA species, a large segment encoding the virus poly-
merase (L) and a small zinc finger motif protein (Z), and a small
segment encoding the virus nucleoprotein (NP) and glycoprotein
precursor (GPC) (8). The arenavirus GPC is synthesized initially
as a single polypeptide that is sequentially cleaved by cellular signal
peptidases and then by the cellular proprotein convertase (PC)
subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P) (9–12).
Processing of GPC yields the N-terminal glycoprotein 1 (GP1),
implicated in binding to cellular receptors, and the transmem-
brane GP2, which mediates fusion. Maturation of GPC by SKI-1/
S1P is strictly required for the production of infectious particles
and viral spread (9–12). The ability of newly emerging arenavi-
ruses to hijack human SKI-1/S1P forGPCprocessing thus appears
to be a crucial requirement for zoonotic transmission and the
ability to cause human disease.Moreover, inhibitors of SKI-1/S1P
show potent antiviral activity with a low probability of viral resis-
tance, identifying SKI-1/S1P as a promising “druggable” target for
therapeutic antiviral intervention (13–16).
SKI-1/S1P is initially synthesized as an inactive precursor zy-
mogen comprising a signal peptide, an N-terminal prodomain, a
catalytic domain, and a transmembrane domain followed by a
basic cytosolic tail. Upon translocation into the endoplasmic re-
ticulum (ER), SKI-1/S1P zymogen activation involves autocata-
lytic maturation by sequential cleavages of the N-terminal prodo-
main, first at sites B= andB (RKVF2RSLK1372) and then at site C
(RRLL1862) and the newly described site C= (RRAS1662) (bold-
face and underlining highlight conserved residues) (17). The end
product, SKI-1/S1P C, represents the fully mature enzyme (18,
19). A unique feature of SKI-1/S1P is its ability to recognize and
process substrates in distinct compartments of the secretory path-
way. LASV GPC is already processed by SKI-1/S1P in the ER/cis-
Golgi, whereas endogenous substrates, such as sterol regulatory
element-binding proteins (SREBPs) or activation transcription
factor 6 (ATF-6), are processed in the median Golgi compartment,
andLCMVGPCundergoes cleavage in lateGolgi compartments (20,
21). These observations suggest that the activity of the protease is
somehow regulated in a compartment-specific manner.
Conventional approaches to the study of the processing of pu-
tative viral SKI-1/S1P substrates in a quantitative manner made
use of homogeneous biochemical assays including synthetic pep-
tides and soluble enzyme (22, 23). These systems have greatly con-
tributed to our current understanding of SKI-1/S1P-mediated
GPCprocessing.However, in some cases, these peptide-based sys-
tems failed to reproduce the SKI-1/S1P-mediatedGPC processing
observed in the context of viral infection, as illustrated by the lack
of cleavage of peptides derived from LCMV or GTOV GPC (22,
23). Since full-length GPCs of both LCMV and GTOV are readily
cleaved in a range of mammalian cells (9, 11, 12), the lack of
processing suggests that these otherwise powerful in vitro assays
do not accurately recapitulate the authentic cellular environment.
Here we employ a recently developed robust and reliable cell-
based assay for the detection of endogenous SKI-1/S1P activity
(17) to characterize arenavirus GPC processing in a quantitative
manner. First, we show that our sensor accurately reproduces key
features of SKI-1/S1P-mediated processing of authentic arenavi-
rus GPCs, including LCMV GPC, and we define the minimal
structures necessary and sufficient to confer specificity and a sub-
cellular location of cleavage. In the next step, we use our sensor to
predict the efficient processing of the GPC of the newly emergent
LUJV by human SKI-1/S1P and to define the cleavage site, pro-
viding a proof of concept. Last, we use our sensor to investigate the
efficiency of processing of known and newly emergent pathogenic
and nonpathogenic NW arenaviruses by human SKI-1/S1P in or-
der to assess their zoonotic potential. Our SKI-1/S1P sensor rep-
resents a rapid and robust test system for assessment of the pro-
cessing of putative cleavage sites derived from GPCs of newly
discovered arenaviruses by the SKI-1/S1P of humans or any other
species, based solely on genetic information.
MATERIALS AND METHODS
Antibodies.Mouse monoclonal antibody (MAb) 83.6 against LCMV GP
has been described previously (24). The rabbit anti-Gaussia luciferase
(anti-GLuc) antibody was from New England BioLabs, and the mouse
anti--tubulin MAb was obtained from Sigma. Polyclonal rabbit anti-
mouse and polyclonal goat anti-rabbit secondary antibodies conjugated
to horseradish peroxidase (HRP) were purchased from Dako.
Plasmids and constructs. Plasmids coding for wild-type (WT) full-
length SKI-1/S1P and the mutant SKI-1/S1P-KDEL have been described
previously (19), as have expression plasmids for LASVGPC, LCMVGPC,
and LCMV GPC containing the cleavage sequence RRLL (LCMV-RRLL
GPC) (11, 14, 25). An expression plasmid containing the full-length
cDNA of LUJVwas provided by the Viral Special Pathogens Branch of the
U.S. Centers for Disease Control and Prevention, Atlanta, GA. The SKI-
1/S1P sensors containing the 9-mer recognition sequence of LASV GPC,
IYISRRLL2G, and the uncleavable sequence (U-LASV) IYISEELL2G
have been described in a previous report (17). Sensors containing 9-mer
peptides derived from arenavirus GPCswere generated by the insertion of
specific oligonucleotides coding for the designed sequence flanked by
unique restriction sites at the 3= and 5= ends, as reported previously (17).
This cassette insertion method allows for the rapid generation of con-
structs containing different cleavable motifs. Sequences of the specific
oligonucleotides will be provided upon request.
Cell culture and transfection. HEK293T human embryonic kidney
cells and A549 human lung epithelial cells were maintained in DMEM
(Dulbecco’s modified Eagle’s medium; Invitrogen) supplemented with
10% (vol/vol) fetal bovine serum (FBS) and 100 U/ml penicillin and 0.1
mg/ml streptomycin (P/S). Chinese hamster ovary (CHO) K1 cells were
maintained in DMEM–Ham’s F-12 medium (1:1; Biochrom AG) supple-
mented with 10% FBS and P/S. SKI-1/S1P-deficient CHO-K1-derived
SRD12B cells (26), provided byMichael S. Brown and Joseph L. Goldstein
(University of Texas Southwestern Medical Center, Dallas, TX), were
grown in CHO-K1 medium supplemented with 5 g/ml cholesterol
(Sigma), 20 M sodium oleate (Sigma), and 1 mM sodium mevalonate
(Sigma). All cell lines were kept at 37°C under 5% CO2. SRD12B and
CHO-K1 cells were transfected with Lipofectamine as reported elsewhere
(27). Sensor transfections were performed using polyethylenimine (PEI)
obtained fromPolysciences as described previously (17). At 4 h posttrans-
fection, solutions were replaced by fresh medium. Transfection efficien-
cies were evaluated after the time points indicated on the figures by detec-
tion of the enhanced green fluorescent protein (EGFP) reporter.
Western blot analysis. Media were collected, and cells were washed
twice with cold phosphate-buffered saline (PBS), followed by lysis in cell
lytic buffer (Sigma) supplemented with cOmplete, Mini, protease inhib-
itor cocktail (Roche) according to the manufacturer’s instructions. Cell
lysates were cleared by centrifugation (15,000 rpm, 10 min) and superna-
tants transferred to new tubes. Conditionedmedia were centrifuged twice
(1,500 rpm, 5 min) to remove cellular debris, and supernatants were like-
wise transferred to new tubes. Samples were mixed 1:1 with 2 SDS-
polyacrylamide gel electrophoresis (PAGE) sample buffer containing 100
mMdithiothreitol (DTT) andwere boiled for 5min at 95°C. Sampleswere
separated by SDS-PAGE and were blotted onto nitrocellulose mem-
branes. Membranes were blocked in 3% (wt/vol) skim milk in PBS con-
taining 0.2% (wt/vol) Tween 20 (Sigma), and proteins were detected by
overnight incubation at 4°C with mouse MAb 83.6 against LCMV GP
(1:1,000), an anti-V5 MAb (1:5,000), a rabbit anti-GLuc antibody (1:
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5,000), and a mouse anti--tubulin MAb (1:10,000) as primary antibod-
ies, combined with HRP-conjugated polyclonal rabbit anti-mouse (1:
3,000) and polyclonal goat anti-rabbit (1:6,000) secondary antibodies.
Membranes were developed by chemiluminescence using a LiteAblot kit
(Euroclone). Signals were acquired by an ImageQuant LAS 4000 Mini
system (GEHealthcare Life Sciences) or by exposure to X-ray films.West-
ern blot results were quantified with ImageQuant TL software (GE
Healthcare Life Sciences).
Detection of SKI-1/S1P sensor processing by a luciferase assay. Sen-
sors were transfected into HEK293T cells using PEI as described above.
After the indicated time posttransfection, conditioned medium was har-
vested and cleared by centrifugation, and secreted GLuc activity was de-
tected as described in reference 17. Briefly, conditioned medium (3.5 l)
was manually distributed in a white half-volume 96-well plate and was
mixedwith 60l of a substrate solution composed of coelenterazine stock
(Molecular Probes) diluted in PBS (1:5,000). A stock solution was pre-
pared by dissolving coelenterazine in acidifiedmethanol at 160g/ml and
was stored at80°C. A TriStar LB 941 microplate reader (Berthold) was
used to measure the luminescence of cell medium samples. Substrate in-
jection was performed automatically and was immediately followed by a
luminescence reading. The substrate solution was freshly prepared each
time.
Retroviral pseudotypes. A recombinant Moloney murine leukemia
virus (MLV) containing a luciferase reporter was pseudotyped with LUJV
GPC, LASV GPC, or the G protein of vesicular stomatitis virus (VSV) as
described previously (25). Pseudotypes were serially diluted and were
then added to cell monolayers in 96-well plates. After 1 h, the inoculum
was removed, and cells were first washed briefly and then incubated for 48
h. Infection was quantified using the Steady-Glo high-sensitivity lucifer-
ase reporter gene assay (Promega) in a TriStar LB 941 microplate reader
(Berthold). Retroviral pseudotypes were then concentrated by ultracen-
trifugation at 25,000 rpm and 4°C for 2 h using a SW28 rotor. Superna-
tants were discarded after centrifugation and pellets resuspended for 16 h
in DMEM–20 mMHEPES (pH 7.5) at 4°C as described previously (28).
Statistical analysis. Assays were carried out in biological triplicates,
and statistical analysis was performed using the GraphPad Prism software
package. One-way analysis of variance (ANOVA) was used for multiple
comparisons, and aP value of 0.01was set as the threshold for significance.
RESULTS
A cell-based SKI-1/S1P sensor recapitulates the specificity and
subcellular location of SKI-1/S1P processing of LASV and
LCMV GPCs. Previous studies with a range of mammalian cells
revealed that theGPCs of LCMVand LASVboth undergo efficient
SKI-1/S1P-dependent processing throughout the viral life cycle
(9–11, 29). However, studies on the processing of the bona fide
SKI-1/S1P cleavage sites of LASV and LCMV GPCs using estab-
lished in vitro assays based on chromogenic peptides gave mixed
results. A methyl coumaride (MCA)-conjugated-peptide derived
from the LASV GPC sequence from residue P1 to P8 (IYISRRLL)
proved to be an excellent substrate, whereas the corresponding
sequences from LCMV ARM53b GPC (KFFTRRLA) and its vari-
ant clone-13 (KFLTRRLA) were resistant to in vitro cleavage (22,
23). Subsequent attempts by our laboratory using longer peptides
covering as many as 20 amino acids surrounding the SKI-1/S1P
cleavage site of LCMV GPC combined with sensitive mass spec-
trometry to assess cleavage failed to show any detectable process-
ing (data not shown), suggesting an inherent problem with the
assay at hand. To overcome this limitation, we employed a newly
developed cell-based sensor for SKI-1/S1P activity to study the
processing of LCMV GPC (17). This assay is based on a chimeric
protein composed of a Gaussia luciferase (GLuc) reporter an-
chored to the membrane by the stump region of SKI-1/S1P
through a cleavable 9-mer peptide derived from residues P1 to P8
and P1= surrounding the sessile peptide bond of the SKI-1/S1P
recognition sites of choice (Fig. 1A). A suitable restriction cassette
allows rapid insertion of any given 9-mer amino acid sequence
into our sensor using synthetic oligonucleotides (17). Upon pro-
cessing, this sensor releases GLuc to the medium, where it can be
FIG 1 Efficient processing of a cell-based sensor of SKI-1/S1P bearing the recognition sequences of LASV and LCMVGPCs. (A) Schematic representation of the
SKI-1/S1P sensor. The SKI-1/S1P-derived stump region and GLuc, as well as the peptide representing the cleavage motif, are indicated. The sequences of the
9-mer peptides representing the cleavage motifs of LASV GPC and the GPCs of LCMV ARM53b and its variant clone-13, as well as the noncleavable control
(U-LASV), are presented. (B and C) Efficient processing of LASV and LCMV sensors by endogenous human SKI-1/S1P. The indicated sensors were transfected
into HEK293T cells using PEI. (B) After 48 h, GLuc activity was detected in the supernatants (Supn) and cell lysates byWestern blotting. The samples loaded for
the supernatants and cell lysates represent 1% and 20% of the total amounts, respectively. Signals presented within the same box are from the same blot. Where
bands have been cut andmoved for clarity of presentation, this is indicated by narrow vertical lines. The uncleaved sensor (U-Gluc) and cleaved GLuc (C-GLuc)
are indicated. (C) GLuc activity was detected in the supernatant by a luciferase assay. Data aremean relative light units (RLU) standard deviations (n 3). (D)
Inhibition of sensor processing by a specific SKI-1/S1P inhibitor. The indicated sensors were expressed in HEK293T cells, followed by treatment with the
SKI-1/S1P inhibitor PF-429242 (20M).At 48 h, GLuc activity was detected in the supernatant as described for panel C. Results aremeans standard deviations
(n 3). DMSO, dimethyl sulfoxide.
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detected using a robust and sensitive luciferase assay. The SKI-1/
S1P membrane anchor ensures correct cellular targeting and op-
timal substrate-enzyme recognition (17). To construct the corre-
sponding sensors, we inserted peptides representing the SKI-1/
S1P recognition site (P1 to P4), the upstreamflanking residues (P5
to P8), and residue P1= of LCMVARM53b (KFFTRRLA2G) and
clone-13 (KFLTRRLA2G), as well as LASV (IYISRRLL2G) (Fig.
1A). As a control, we included a sensor bearing a mutated, non-
cleavable sequence derived from LASV (IYISEELL2G) (under-
lining highlights themutated sites). Upon expression inHEK293T
cells, the sensors for LCMV and LASV GPCs underwent efficient
processing, as assessed by detection of cleaved GLuc in the super-
natants by Western blotting, whereas only background levels of
cleavage were detected for the control sensor (Fig. 1B). By probing
the total protein obtained from cell lysates, we were able to detect
the uncleaved precursor (U-GLuc) and traces of processed GLuc.
However, the amounts of sensor protein in the intracellular frac-
tion detected at the time of lysis corresponded to 5% of the
amounts detected in the supernatants.While the relative amounts
of accumulated cleavedGLuc in the supernatantswere highly con-
sistent between experiments, the ratios of cleaved to uncleaved
sensor in the intracellular pool tended to show more variation.
Quantitative determination of GLuc activity in the supernatant by
a luciferase assay, which represents the actual readout for effi-
ciency of processing, revealed comparable cleavage of the sensors
for LASV and LCMV GPCs (Fig. 1C), in line with the extent of
processing detected byWestern blotting (Fig. 1B). To validate the
specific cleavage of our sensors by SKI-1/S1P, we used the small-
molecule inhibitor PF-429242,which is specific for SKI-1/S1P (30,
31). As shown in Fig. 1D, treatment with PF-429242 reduced sen-
sor processing to the level of the noncleavable probe, verifying
SKI-1/S1P-mediated processing of the LCMV sensors. The effi-
cient processing of sensors bearing the 9-mer peptides derived
fromLCMVARM53b and clone-13GPC indicated that the lack of
cleavage observed in previous assays (22, 23) was an artifact of the
assay format and not an inherent property of the substrate se-
quence. The comparable efficiencies of processing of LCMV and
LASV GPC sensors in human cells match well with the observed
cleavage of full-length GPC either upon expression as a recombi-
nant protein or during viral infection (9–11, 29).
Previous studies revealed that LASV GPC is processed by SKI-
1/S1P in the ER/cis-Golgi, whereas LCMVGPC is cleaved in a late
Golgi compartment, indicating specific processing dependent on
the subcellular location (9, 10). When expressed in SKI-1/S1P-
null SRD12B cells, an SKI-1/S1P variant retained in the ER (SKI-
1/S1P-KDEL) can efficiently cleave LASV GPC but not LCMV
GPC (Fig. 2A). Introduction of the RRLL recognition site into
LCMV GPC (LCMV GPC-RRLL) redirects processing to the ER/
cis-Golgi, as evidenced by efficient cleavage by SKI-1/S1P-KDEL
(Fig. 2A) and as shown in earlier studies (27). To assess the com-
partment specificity of our sensors, we likewise coexpressed our
sensors for LASV and LCMV GPCs with SKI-1/S1P-KDEL and
WT protease in SRD12B cells and monitored processing. In addi-
tion, we included a sensor bearing the sequence KFFTRRLL2G,
corresponding to the recognition sequence present in LCMV
GPC-RRLL, and the uncleavable sensor variant (U-LASV) as a
negative control. Detection of cleaved GLuc by Western blotting
and a luciferase assay revealed more-efficient cleavage of the sen-
sors for LASVandLCMVGPC-RRLLby SKI-1/S1P-KDEL thanof
the LCMV sensor (Fig. 2B and C). In sum, the data indicate that
our sensor bearing 9-mer peptides derived fromLCMVand LASV
GPCs recapitulates key features of the specificity, relative effi-
ciency, and subcellular location of SKI-1/S1P processing of the
authentic viral GPCs.
In the next step, we sought to define the relative contributions
of the actual SKI-1/S1P recognition site (P1 to P4) and flanking
region (P5 to P8) to the specificity, efficiency, and subcellular
location of SKI-1/S1P processing. For this purpose, we generated
FIG 2 LCMV and LASV sensors recapitulate the compartment-specific processing of full-length GPCs. (A) Processing of recombinant LCMV and LASV GPCs
by SKI-1/S1P variants. SKI-1/S1P-deficient SRD12B cells were cotransfected with LCMV GPC, LASV GPC, or LCMV-RRLL GPC and the indicated SKI-1/S1P
variant or an empty vector (pIR). The processing of GPC was assessed by Western blotting using MAb 83.6 against LCMV GP, whose epitope is conserved and
present in the GPC and mature GP2 of LCMV and LASV (24). The positions of GPC and mature GP2 are indicated. Signals presented within the same box are
from the same blot. To quantify the extent of cleavage, the signal intensities for GP2weremeasured and normalized to those for GPCby densitometry as reported
previously (27). The GP2/GPC ratio of WT SKI-1/S1P was set at 1. The diffuse bands observed above and below the GP2 band represent different forms of
glycosylation and were included in the densitometric analysis. The relatively inefficient processing of GPC is a consequence of the limited cotransfection rate. (B
and C) Processing of sensors by SKI-1/S1P variants. The indicated sensors were transfected into SRD12B cells in combination with either SKI-1/S1P-KDEL,WT
SKI-1/S1P, or an empty vector (pIR). (B) After 48 h, processing was monitored by detection of cleaved GLuc (C-GLuc) in supernatants (Supn) and cell lysates
byWestern blotting. The uncleaved sensor (U-Gluc) and C-GLuc are indicated. Signals presented within the same box are from the same blot. (C) GLuc activity
wasmeasured in the supernatant by a luciferase assay as for Fig. 1C. Results of one experiment representative of several independent experiments are shown.Data
are means standard deviations (n 3).
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sensors for LASV and LCMV containing only 5-mer peptides rep-
resenting residues P1 to P4 and P1=.While these truncated sensors
for LASV and LCMV GPC were processed efficiently, Western
blot analysis revealed additional bands, indicating aberrant pro-
cessing (data not shown). Upon coexpression with SKI-1/S1P-
KDEL andWTSKI-1/S1P, we could not observe the compartment
specificity revealed by sensors containing the 9-mer substrate pep-
tide (data not shown). These data suggested that the sequence
comprising P1 to P8 and P1=was necessary and sufficient to define
the specificity, efficiency, and subcellular location of the process-
ing of OW arenavirus GPCs.
Prediction of SKI-1/S1P processing of LUJV GPC using the
SKI-1/S1P sensor.New arenaviruses are rapidly emerging, and in
many cases, viruses could not be isolated and only genetic infor-
mation is available. Considering the variation at the known and
putative SKI-1/S1P cleavage sequences found in the GPCs of are-
naviruses from different clades, a defined consensus sequence
cannot be easily recognized (22, 32). Moreover, the recent discov-
ery of arenaviruses that are only distantly related to the major
clades raises the question of whether these viruses depend on SKI-
1/S1P forGPCprocessing at all. The data obtainedwith our sensor
suggest that knowledge of the sequence comprising P1 to P8 and
residue P1= of the putative GP1/GP2 cleavage site would be nec-
essary and sufficient for testing whether the GPC of any newly
emerging arenavirus can be efficiently processed by human SKI-
1/S1P, which appears to be a prerequisite for productive infection
in humans.
In 2008, a novel arenavirus was found associated with a cluster
of fatal human hemorrhagic fever cases in southern Africa, with a
high case fatality rate of 80% (2). The signs and symptoms of the
disease resemble those of Lassa fever (33), and the new virus,
LUJV, was identified as a phylogenetically distant member of the
Arenaviridae branching from the ancestral node of the OWarena-
viruses (2). Sequence alignments with GPCs from other African
arenaviruses revealed that the putative GP1/GP2 cleavage se-
quence found in LUJV, RKLM2K, is only distantly related to the
sequences of other African arenaviruses, such as LASV and Mo-
peia virus (RRLL2G), Mobala virus (RRLM2S), or Ippy virus
(RRLM2S) (Fig. 3A). In particular, the K residue at P1= was
rather unexpected, since this amino acid had so far never been
found in this position in any cellular or viral SKI-1/S1P substrate,
and very rarely in the substrates of other proprotein convertases.
As a proof of concept, the putative cleavage sequence of LUJVwas
evaluated for SKI-1/S1P processing in our sensor. To this end, the
9-mer sequence HYKVRKLM2K was inserted into our sensor
(Fig. 3B), and processing was assessed; the LASV sensor and the
uncleavable control sensor were used for comparison. When ex-
pressed in HEK293T cells, the LUJV sensor underwent efficient
processing, similar to that of the LASV sensor, as assessed by de-
tection of cleaved GLuc byWestern blotting (Fig. 3C) and a lucif-
erase assay (Fig. 3D). Upon expression in SKI-1/S1P-deficient
SRD12B cells, processing of the LUJV sensor was abrogated, while
efficient cleavage was observed inWT CHO-K1 cells, pinpointing
SKI-1/S1P (Fig. 3C and E). The results obtained with our sensor
suggest that LUJVGPCmay be cleaved by human SKI-1/S1P with
an efficiency comparable to that for LASV GPC. Interestingly,
replacement of K at P1= by A failed to markedly enhance the pro-
cessing of our LUJV sensor by SKI-1/S1P (data not shown), sug-
gesting that human SKI-1/S1P can tolerate a positively charged
amino acid at P1= in the context of the LUJV recognition se-
quence.
To verify the SKI-1/S1P dependence of processing in the con-
text of the authentic GPC, full-length LUJVGPCwas expressed in
SRD12B, CHO-K1, andHEK293T cells, and processing wasmon-
itored by Western blotting. Expression in CHO-K1 cells, but not
in SRD12B cells, resulted in processing of LUJV GPC to an extent
comparable to that of LASVGPC (Fig. 3F), indicating dependence
on SKI-1/S1P. In human cells, the LUJV and LASV GPCs were
processed with similar efficiencies (Fig. 3G). Treatment with the
SKI-1/S1P inhibitor PF-429242 markedly reduced LUJV GPC
processing, again pinpointing SKI-1/S1P (Fig. 3G). In both
CHO-K1 and HEK293T cells, LUJV GPC migrated slightly faster
than the LASV proteins. Lastly, we sought to confirm that SKI-1/
S1P cleavage was crucial for the infectivity mediated by LUJV GP.
Because LUJV is a biosafety level 4 (BSL4) pathogen,workwith the
live virus is restricted to high-containment facilities. Since viral
cell attachment and the entry of OW arenaviruses are mediated
exclusively by the viral GP, we used a well-established retroviral
pseudotype platform to assess the biological function of LUJV
GPC as a function of SKI-1/S1P processing. Recombinant Molo-
neymurine leukemia virus (MLV) containing a luciferase reporter
was pseudotypedwith LUJVor LASVGPCas described previously
(25). As positive and negative controls, we generated MLV pseu-
dotypes bearing the G protein of vesicular stomatitis virus (VSV)
and pseudotypes lacking a GP, respectively. To address the re-
quirement of SKI-1/S1P processing for the formation of infectious
particles, LUJV pseudotypes were generated in the presence or
absence of the SKI-1/S1P inhibitor PF-429242. Briefly, aHEK293-
derived packaging cell line expressing MLV Gag and Pol was
transfected with the MLV genomic plasmid and expression con-
structs for the viral GPC, followed by treatment with PF-429242
during the production phase of the pseudotypes. Supernatants
were harvested, and fresh monolayers of A549 cells were infected
with serial dilutions of pseudotypes. Detection of infection after
48 h indicated that LUJV and LASV pseudotypes produced in cells
treatedwith PF-429242 showedmarkedly reduced infectivity (Fig.
3H), indicating a requirement for SKI-1/S1P-mediated cleavage
for the biological function of LUJV GPC. As expected, VSV pseu-
dotypes were not affected by treatment with the SKI-1/S1P inhib-
itor. Detection of LUJV GP species in MLV pseudotypes concen-
trated by ultracentrifugation revealed the absence of GPC and
GP2 in particles produced in the presence of PF-429242 (Fig. 3I).
Notably, despite high expression levels of GPC in total-cell lysates,
MLV pseudotypes produced in cells with active SKI-1/S1P con-
tained only mature GP2 (Fig. 3I). This situation is reminiscent of
those of LASV, LCMV, and JUNV, where GPC processing by SKI-
1/S1P is likewise required for incorporation into virion particles,
and infection of SKI-1/S1P-deficient cells results in the formation
of “nude” virion particles devoid of GP1/GP2 spikes (10–12). The
correct prediction of SKI-1/S1P processing of the GPC of a dis-
tantly related arenavirus such as LUJV illustrates the potential of
our sensor to assess the SKI-1/S1P dependence and relative effi-
ciency of cleavage of the GPCs of novel arenaviruses.
Processingof the SKI-1/S1P recognition sequences of cladeB
NWarenaviruses doesnot correlatewith virulence.All currently
known human-pathogenic NW arenaviruses—JUNV, MACV,
GTOV, SABV, and CHAV—belong to clade B, where they do not
form a separate sublineage but are phylogenetically interspersed
with nonpathogenic viruses, such as Tacaribe virus (TACV); vi-
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ruses so far not associated with human disease, such as Amapari
virus (AMPV) and Cupixi virus (CPXV); and viruses whose dis-
ease potential remains unknown, such as Ocozocoautla de Espi-
nosa virus (OCEV), a novel, uncultured arenavirus (Fig. 4A). The
capacity of JUNV, MACV, GTOV, SABV, and CHAV to cause
disease in humans has been linked to their ability to use human
transferrin receptor 1 (hTfR1) (34). In contrast, the nonpatho-
genic clade B viruses use TfR1 derived from their reservoir hosts
and other species, but not from humans (35). In addition to the
ability to recognize human TfR1, the efficiency of GPC processing
by human SKI-1/S1P likely represents an important host determi-
nant for virulence. Therefore, using our sensor platform,we tested
if the human disease potential of clade B viruses correlates with
their efficiency at using human SKI-1/S1P for GPC processing.
First, we generated a sensor containing a 9-mer sequence cor-
responding to the known SKI-1/S1P recognition site of JUNV
(QLPRRSLK2A) (the underlined sequence is the canonical
recognition site). In order to validate the SKI-1/S1P specificity
of processing, we expressed the sensors for JUNV and LASV in
the presence and absence of the inhibitor PF-429242 in
HEK293T and HeLa cells. The uncleavable U-LASV sensor was
included as a negative control. Detection of sensor processing
by Western blotting (Fig. 4B) and measurement of GLuc activ-
ity in the cell culture supernatant (Fig. 4C) consistently re-
FIG 3 Prediction of SKI-1/S1P processing of LUJVGPC by using the SKI-1/S1P sensor. (A) Sequence alignment of LUJV and LASVGPCs. Green and red arrows
indicate sequences corresponding to GP1 and GP2, respectively, and a yellow arrow indicates the cleavable 9-mer sequence. (B) The cleavable 9-mer sequences
present in the sensors. (C to E) Efficient and specific processing of the LUJV sensor by SKI-1/S1P in human and hamster cells. The indicated sensors were
transfected intoHEK293T, CHO-K1, and SKI-1/S1P-deficient SRD12B cells. (C) Processing by sensors was detected byWestern blotting as described for Fig. 1B.
The uncleaved sensor (U-Gluc) and cleavedGLuc (C-GLuc) are indicated. Signals presentedwithin the same box are from the same blot. Rearrangement of bands
for clarity is indicated by narrow vertical lines. (D and E) For quantitative assessment of sensor cleavage, GLuc activity was measured in the supernatants of
transfected HEK293T cells sampled at the indicated time points (D) and in the supernatants of CHO-K1 and SRD12B cells after 48 h (E) as described for Fig. 1C.
Results are means  standard deviations (n  3). (F) Specific processing of LUJV GPC by SKI-1/S1P. Full-length LUJV and LASV GPCs were expressed in
SRD12B and CHO-K1 cells, and an empty vector (Mock) was used as a control. After 48 h, total-cell lysates were prepared, and GPC processing was examined
by Western blotting as described for Fig. 2A. The GPC precursor and mature GP2 are indicated, and tubulin (Tub) was detected as a loading control. Signals
presented within the same box are from the same blot. (G) Cleavage of LUJV GPC in human cells depends on SKI-1/S1P. HEK293T cells were transfected with
the LASV or LUJV GPC, followed by treatment with the SKI-1/S1P inhibitor PF-429242 (20 M) throughout the experiment. After 48 h, total-cell lysates were
probed for GPC processing by Western blotting as for panel F. Signals presented within the same box are from the same blot. (H) Processing of LUJV GPC is
required for productive cell entry. LUJV GPC, LASVGPC, or VSVGwas incorporated into a retroviral pseudotype bearing a luciferase reporter in its genome in
the presence and absence of PF-429242 (20 M) as described previously (25). An empty vector (pIR) served as a negative control. After 48 h, pseudotypes were
harvested, and serial dilutions were prepared to infect fresh monolayers of A549 cells. Pseudotype infection was measured after 48 h by a Steady-Glo high-
sensitivity luciferase reporter gene assay. Results are means standard deviations (n 3). (I) Detection of GPC processing in pseudotypes. MLV pseudotypes
containing LUJV GPC and pseudotypes devoid of GPC (EGFP) were produced as described for panel H in the presence and absence of PF-429242 (20 M).
Supernatants were cleared of cellular debris and were then subjected to ultracentrifugation through a sucrose cushion as described in Materials and Methods.
Pellets containing the pseudotypes were solubilized, and the presence of GPC was detected by Western blotting as for panel F. The total-cell lysate was used for
comparison. The GPC precursor andmature GP2 are indicated. Note the absence of specific GPC or GP2 signals in the pseudotype preparations produced in the
presence of the SKI-1/S1P inhibitor.
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vealed slightly more efficient cleavage of the JUNV sensor than
of the LASV sensor. The processing of both sensors was mark-
edly reduced in the presence of PF-429242, validating the spec-
ificity of SKI-1/S1P (Fig. 4B and C).
In order to compare the efficiencies of SKI-1/S1P processing of
different clade B viruses, we generated sensors containing the
highly divergent 9-mer sequences surrounding the putative SKI-
1/S1P sites of the pathogenic viruses MACV, GTOV, SABV, and
CHAV, the nonpathogenic viruses TACV,AMPV, andCPXV, and
the virus of unknown pathogenicity OCEV (Fig. 4A). Upon ex-
pression in HEK293T cells, all sensors underwent efficient pro-
cessing, yielding GLuc fragments of the expected size (Fig. 4D).
Quantitative assessment of sensor processing by detection of
GLuc release in the supernatant revealed only minor differences
between pathogenic and nonpathogenic clade B NW arenaviruses
across several experiments (Fig. 4E). Our data indicate that the
efficiency ofNWarenavirusGPCprocessing by human SKI-1/S1P
does not correlate with virulence. Unlike the human form of TfR1
at the level of cell entry, human SKI-1/S1P apparently does not
represent a barrier for the zoonotic transmission of clade B NW
viruses.
The existing SKI-1/S1P recognition sites of LASV and JUNV
GPCs appear suboptimal. Previous studies revealed that the SKI-
1/S1P recognition sites of LASV and other OW arenaviruses
mimic the RRLL sequence of the Cmaturation site, whereas clade
B NW viruses resemble the B autoprocessing site RSLK (22).
Moreover, aromatic “signature” residues at position P7 of OW
arenavirus GPCs, but not NW arenavirus GPCs, enhance SKI-1/
S1P processing (32). Intrigued by the lack of the aromatic residue
at P7 in cladeBNWviruses and the very distinctmotifs at P1 to P4,
we generated chimeric sensors with cleavable peptides comprising
LASV P1 to P4 combined with LCMV P5 to P8 (LCMV-LASV) or
JUNV P5 to P8 (JUNV-LASV), as well as JUNV P1 to P4 com-
bined with LASV P5 to P8 (LASV-JUNV) (Fig. 5A). Upon expres-
sion of the sensors in human cells, we observed consistently en-
hanced processing of the chimeric sensor JUNV-LASV and, to a
lesser extent, of LCMV-LASV and LASV-JUNV relative to that of
sensors containing the parental sequences (Fig. 5B and C). These
findings provide the first hints that existing viral GPCs may not
contain the most cleavable sites for human SKI-1/S1P.
DISCUSSION
Subtilisin/kexin type proprotein convertases (PCs) constitute a
family of nine conserved calcium-dependent serine endoproteases
and include the basic PCs (PC1/3, PC2, furin, PC4, PACE4,
PC5/6, and PC7) as well as the nonbasic PCs (SKI-1/S1P and
PCSK9) (36). A wide range of emerging human-pathogenic vi-
ruses have evolved to hijack cellular PCs for the processing of their
envelope glycoproteins, which is essential for productive infec-
tion. Based on their crucial roles in transmission and subsequent
virus-host interaction, PCs appear to be important determinants
for the host range and tissue tropism, and hence for the disease
FIG 4 The efficiency of SKI-1/S1P processing of clade B New World arenavirus GPCs does not correlate with virulence. (A) Schematic of the phylogenetic
relationships of the clade B NW viruses studied. The neighbor-joining tree is based on the amino acid sequences of the GPCs of the indicated viruses. The
sequences of the 9-mer peptides present in the sensors are indicated. (B and C) Processing of the JUNV sensor compared to that of the LASV sensor. A sensor
containing a 9-mer peptide derived from JUNV GPC, the LASV sensor, and the uncleavable sensor (U-LASV) were transfected into HEK293T and HeLa cells,
followed by treatmentwith the SKI-1/S1P inhibitor PF-429242 (20M). (B) At 48 h, GLucwas detected byWestern blotting. The uncleaved sensor (U-Gluc) and
cleaved GLuc (C-GLuc) are indicated, and tubulin (Tub) was used as a loading control. (C) GLuc activity was detected in the supernatant by a luciferase assay.
Results, expressed in relative light units (RLU), are means standard deviations (n 3). Data were analyzed by one-way ANOVA (***, P 0.01; **, P 0.05).
(D and E) Efficient processing of the sensors for clade B NW arenaviruses by human SKI-1/S1P. The indicated sensors were transfected into HEK293T cells. (D)
After 48 h, sensor processing was examined byWestern blotting. The uncleaved sensor and cleaved GLuc are indicated. (E) GLuc activity in the supernatant was
detected by a luciferase assay as for Fig. 1C. Results of one experiment representative of several independent experiments are shown. Data are means standard
deviations (n 3).
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potential, of a virus. As essential cellular factors for viral infection,
and as enzymes, they also represent promising “druggable” targets
for antiviral therapeutics. In contrast to basic PCs, which are used
by a wide variety of viruses to process their envelope glycoproteins
(37), the eighth member of the PC family, SKI-1/S1P, is hijacked
by only two families of emerging viruses, the Arenaviridae and
somemembers of the Bunyaviridae (9, 10, 12, 38). The processing
sites of arenavirus GPCs are unique and differ from cellular sub-
strates because of their mimicry of the autoprocessing motifs of
SKI-1/S1P (22). Moreover, LASVGPC undergoes SKI-1/S1P pro-
cessing early in the secretory pathway, while LCMVGPC has been
shown to be processed in a late Golgi compartment (9, 10, 27).
Interestingly, membrane-associated SKI-1/S1P is found predom-
inantly in the median Golgi compartment, where most cellular
SKI-1/S1P substrates are cleaved (39). The apparently nonover-
lapping subcellular localizations of viral and cellular substrates
may have evolved to avoid perturbation of the endogenous func-
tion of SKI-1/S1P. Indeed, SKI-1/S1P-mediated processing of
ATF-6 in the context of the host cell’s unfolded protein response is
not perturbed by arenavirus infection, despite high levels of GPC
expression (29).
In the present study, we evaluated a recently developed cell-
based molecular sensor of SKI-1/S1P activity for the quantitative
assessment of SKI-1/S1P-mediated cleavage of arenavirus GPCs
derived from different viral clades, including viruses that have not
yet been isolated. Using the sequences of the well-studied LASV
and LCMVGPCs as an experimental paradigm, we demonstrated
that in the context of our sensor, a 9-mer substrate peptide repre-
senting positions P1 to P8 and P1= of the SKI-1/S1P cleavage site is
necessary and sufficient to recapitulate the specificity, efficiency,
and subcellular location of processing observed in the authentic
GPC. Moreover, our sensor allowed study of the processing of
viral SKI-1/S1P recognition sequences that were not processed in
classical in vitro assays, as illustrated by peptides derived from
LCMVGPC (23) and GTOVGPC (22). Our data show that subtle
changes in the 9-mer sequence at the cleavage site have drastic
effects on the efficiency and subcellular localization of SKI-1/S1P-
mediatedmaturation. Adaptations enabling the virus to efficiently
hijack human SKI-1/S1P will therefore likely result in amino acid
changes within the crucial 9-mer peptide surrounding the SKI-1/
S1P cleavage site. As a consequence, our sensor may be a suitable
tool for making a first prediction as to whether any novel arena-
virus GPC is processed by human SKI-1/S1P and, if so, to what
extent the virus will be capable of using the human form of the
protease. For a proof of concept, we used our sensor to predict
SKI-1/S1P processing of the GPC of LUJV, which was recently
genetically characterized in a cluster of fatal hemorrhagic fever
cases in southernAfrica (2). Phylogenetic analysis identified LUJV
as an outlier within the OW arenaviruses, and the sequence
RKLM2K at the putative GP1/GP2 border deviated significantly
from the SKI-1/S1P processing sites of other arenaviruses (32).
Despite these important differences, our LUJV sensor underwent
efficient processing by human SKI-1/S1P, similarly to our sensor
for LASV. Subsequent validation in the context of the authentic
full-length GPC using a pseudotype platform confirmed the SKI-
1/S1P dependence of LUJV GPC processing for viral entry into
human cells. Interestingly, replacement of the unusual residue K
at P1= byA,which ismore common in cellular and viral substrates,
did not further enhance the SKI-1/S1P processing of our LUJV
sensor. This suggests that the existing 9-mer sequence flanking the
SKI-1/S1P recognition site present in LUJV GPC has already un-
dergone adaptation enabling it to hijack human SKI-1/S1P effi-
ciently, explaining, in part, its virulence in humans (2, 33). Our
sensor allows an assessment of the effects of mutations occurring
within the 9-mer peptide on SKI-1/S1P cleavage. However, muta-
tions in other parts of the GPC or changes in posttranslational
modifications, in particular N- and O-glycosylation, may affect
GPC processing in a way that cannot be detected in our system.
Since the 1950s, the clade B NW arenaviruses JUNV, MACV,
GTOV, SABV, and CHAV have emerged and caused outbreaks of
human hemorrhagic fevers with high mortality. Pathogenic NW
viruses occur in sublineages together with nonpathogenic viruses,
e.g., JUNV with the closely related nonpathogenic virus TACV.
Important differences in the host adaptation of arenaviruses are
linked to their zoonotic disease potential. All pathogenic NW are-
naviruses can use hTfR1 for cell attachment, whereas nonpatho-
genic viruses are restricted to TfR1 orthologues of other species
(34). The ability to use hTfR1 is absolutely predictive of the po-
FIG 5 The existing SKI-1/S1P recognition sites of LASV and JUNV GPC appear suboptimal. (A) The 9-mer recognition sequences present in the WT and
chimeric sensors. (B and C) Sensors containing chimeric 9-mer sequences show enhanced processing. (B) The indicated sensors were transiently
transfected into HEK293T cells, and processing was detected by Western blotting. The uncleaved sensor (U-Gluc) and cleaved GLuc (C-GLuc) are
indicated. (C) GLuc activity in the supernatant was measured as described for Fig. 1C. Results of one experiment representative of several independent
experiments are shown. Data are means  standard deviations (n  3).
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tential to cause severe disease in humans, and structural studies
suggest that minor changes in GP1 could allow nonpathogenic
viruses to recognize hTfR1 (35, 40). Once the virus is inside the
cell, productive infection critically depends on the ability of the
virus to hijack human SKI-1/S1P for efficient GPC processing
(9–12). Intriguingly, several attempts to select for SKI-1/S1P-in-
dependent escape variants of LCMV and JUNV have failed (12,
14), suggesting that these arenaviruses are unlikely to adapt rap-
idly to use another cellular protease for GPC processing, and thus
revealing human SKI-1/S1P as an important host factor that crit-
ically influences the efficiency of viral multiplication. Clinical and
experimental studies show that high viral titers early in disease are
strong predictors of fatal outcomes in arenaviral hemorrhagic fe-
vers (41, 42). Since GPC maturation is crucial for infectious virus
production, rather subtle quantitative differences in the efficiency
of processing of distinct arenavirus GPCs by human SKI-1/S1P
may result in different viral loads and may influence disease out-
come. Using our sensor, we performed a quantitative analysis of
the processing of the 9-mer peptides derived fromGPCs of clade B
NW arenaviruses with distinct disease potential. Despite the wide
diversity of sequences, our studies revealed very similar efficien-
cies of processing by human SKI-1/S1P. These data suggest that
once the barrier of human receptor use is overcome, nonpatho-
genic NW viruses could efficiently use human SKI-1/S1P, which
does not represent a species barrier.
Previous studies by us and others have revealed that amino acid
residues within the flanking region comprising P5 to P8 can affect
the efficiency of arenavirus GPC processing (23, 32). In particular,
OWGPC sequences contain an aromatic “signature” residue at P7
that promotes more-efficient interaction with the protease, en-
hancing processing (32). The aromatic “signature” residue at P7 is
absent from most NW arenavirus GPCs, except for those of
OCWV and CPXV. However, in this context, the F at position P7
does not enhance SKI-1/S1P processing. Using our sensor, we
combined the P1-to-P4 sequence of LASV with the P5-to-P8 se-
quence of JUNV, and vice versa. Rather unexpectedly, the newly
generated chimeric sequence JUNV-LASV was cleaved signifi-
cantly more efficiently than the parental viral sequences, which
belong to the best-known substrates for SKI-1/S1P. We are, of
course, aware of the artificial nature of our sensor system contain-
ing these chimeric sequences. Nevertheless, the data provide a first
hint that the 9-mer SKI-1/S1P recognition sequences of existing
arenavirus GPCs have not yet evolvedmaximum cleavability. The
reasons for this are currently unclear, but onemight speculate that
having “suboptimal” SKI-1/S1P recognition sites in their GPCs
may limit the multiplication of viruses in their natural reservoir
species, thereby preventing overt pathology.
In sum, our SKI-1/S1P sensor represents a rapid and robust
test systemwithwhich to assess the processing of putative cleavage
sites derived from the GPCs of newly discovered arenaviruses by
human SKI-1/S1P, based solely on sequence information. Consid-
ering the promise of SKI-1/S1P as a “druggable” target for antivi-
rals (13, 14) and the availability of small-molecule inhibitor can-
didates (15, 16), the SKI-1/S1P dependence of a newly emerging
pathogenic arenavirus may open the possibility for therapeutic
antiviral intervention. Furthermore, in SKI-1/S1P-null cells, our
sensor can be used to assess the processing of arenavirus GPCs by
SKI-1/S1P orthologues derived from other species. While our
present study focused on SKI-1/S1P and arenaviruses, we are cur-
rently developing sensors of a similar design for the basic PCs that
are responsible for the processing of a plethora of viral envelope
GPs in a wide range of species. Our goal is to provide our sensor
platform to the virology research community for rapid and cost-
effective evaluation of viral GP processing by human PCs, which
may contribute to current research and preparedness to confront
the threat of emerging viruses.
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